Latin America

Given the wide geographic diversity and area covered by Latin America, given the diversity of product issues, and given the diversity of sophistication of the regulatory authorities in the region, a presence in only one country would not suffice to cover FDA needs in the region. FDA therefore plans to establish a presence in San Jose, Costa Rica and Mexico City, Mexico, and perhaps another location to be determined. The Latin America FDA office will focus efforts primarily on food and feed safety and protection issues and will focus medical product safety issues on supporting more in depth the efforts concerning clinical trials regulatory oversight and regulatory oversight of product manufacturing quality.

Latin America Office

__________

<<Return to International Programs and Activities